As the global burden of retinal and ocular diseases continues to rise, the race to develop safer, longer-lasting, and less invasive treatments is accelerating, and at the heart of that challenge lies drug delivery. The 4th Ophthalmic Drug Delivery Summit arrives at a pivotal moment, bringing together 80+ leading experts from pharma and biotech to tackle the toughest delivery hurdles limiting the impact of cutting-edge therapeutics.
With industry momentum building around sustained-release technologies, suprachoroidal administration, and innovative device-drug combinations, this summit is your gateway to the breakthroughs redefining ocular treatment. From translating long-acting formulations into clinical success to navigating regulatory complexities early, this is the only event dedicated to transforming how and where ophthalmic therapies work - making it a must-attend for anyone shaping the future of eye care.